Trombocitopenia immunologica indotta dall'eparina
M Alhenc-Gelas, A Lillo-Lelouët, AM Fischer - EMC-Anestesia …, 2012 - Elsevier
La trombocitopenia immunologica indotta dall'eparina (TIE) è una patologia iatrogena
generata dalla comparsa di immunoglobuline G dirette contro un complesso formato tra il …
generata dalla comparsa di immunoglobuline G dirette contro un complesso formato tra il …
Thrombopénies induites par l'héparine
MB Saida, S Guermazi - Revue Francophone des Laboratoires, 2013 - Elsevier
Résumé Les thrombopénies induites par l'héparine de type II sont une complication immuno-
allergique redoutable des traitements par l'héparine, plus fréquente avec les héparines non …
allergique redoutable des traitements par l'héparine, plus fréquente avec les héparines non …
[PDF][PDF] How I treat heparin-induced thrombocytopenia (HIT)
Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug effect induced by
plateletactivating antibodies against multimolecular complexes of platelet factor 4 and …
plateletactivating antibodies against multimolecular complexes of platelet factor 4 and …
Coagulation Measurement and Optimisation in Cardiac Surgery
P Johnson, A Westbrook - Perioperative Considerations in …, 2012 - books.google.com
Coagulation is a complex physiological balancing mechanism that maintains haemostasis
when blood vessels are injured. A hypercoaguable state as seen in early sepsis, cancer or …
when blood vessels are injured. A hypercoaguable state as seen in early sepsis, cancer or …
[PDF][PDF] Blood First Edition Paper, prepublished online January 13, 2012; DOI 10.1182/blood-2011-11-376293
Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug effect induced by
plateletactivating antibodies against multimolecular complexes of platelet factor 4 and …
plateletactivating antibodies against multimolecular complexes of platelet factor 4 and …
[PDF][PDF] Thrombopenies iatrogènes
B Megarbane, L Drouet, I ElAlamy - srlf.org
En réanimation, la découverte d'une thrombopénie est un problème quotidien: la difficulté
est d'en reconnaître l'origine qui va conditionner sa prise en charge. Les patients de …
est d'en reconnaître l'origine qui va conditionner sa prise en charge. Les patients de …
[PDF][PDF] Evaluierung der Prothrombinase-induzierten Gerinnungszeit zum Monitoring der Antikoagulation mit niedermolekularen Heparinen und Heparinoiden
K Wildberger - 2011 - openscience.ub.uni-mainz.de
Ziel der vorliegenden Studie ist es, zu evaluieren, ob die PiCT bei unterschiedlichen
Medikamenten und verschiedenen Einflussfaktoren die gleichen Messwerte liefern kann wie …
Medikamenten und verschiedenen Einflussfaktoren die gleichen Messwerte liefern kann wie …
Direct thrombin inhibitors: An alternative to heparin during extracorporeal circulation?
A Assmann, U Boeken, P Feindt… - Zeitschrift für Herz-, Thorax …, 2010 - Springer
Zusammenfassung Trotz zahlreicher Weiterentwicklungen der Herz-Lungen-Maschine
(HLM) in den letzten Jahrzehnten ist unfraktioniertes Heparin nach wie vor der Goldstandard …
(HLM) in den letzten Jahrzehnten ist unfraktioniertes Heparin nach wie vor der Goldstandard …
[PDF][PDF] Trombocytopenia indukowana heparyną-zasady rozpoznawania i leczenia Heparin induced thrombocytopenia-principles of diagnosis and treatment
M Wąsowicz, M Meineri, A Vegas - researchgate.net
Summary Heparin Induced Thrombocytopenia (HIT) is rare but potentially life-threatening
disorder. HIT is an immune reaction associated with formation of antibodies directed against …
disorder. HIT is an immune reaction associated with formation of antibodies directed against …
Drugs that affect blood coagulation, fibrinolysis, and hemostasis
JK Aronson - Side Effects of Drugs Annual, 2010 - Elsevier
Publisher Summary This chapter discusses the adverse effects of drugs that affect blood
coagulation, fibrinolysis, and hemostasis. Calciphylaxis (vascular calcification, thrombosis …
coagulation, fibrinolysis, and hemostasis. Calciphylaxis (vascular calcification, thrombosis …